nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.121	0.213	CbGbCtD
Esomeprazole—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.121	0.213	CbGbCtD
Esomeprazole—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.077	0.136	CbGbCtD
Esomeprazole—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.052	0.092	CbGbCtD
Esomeprazole—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0507	0.0896	CbGbCtD
Esomeprazole—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0496	0.0878	CbGbCtD
Esomeprazole—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0442	0.0782	CbGbCtD
Esomeprazole—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0259	0.0459	CbGbCtD
Esomeprazole—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0245	0.0433	CbGbCtD
Esomeprazole—ATP4B—Ion transport by P-type ATPases—ATP2C2—chronic obstructive pulmonary disease	0.0181	0.176	CbGpPWpGaD
Esomeprazole—ATP4A—Ion transport by P-type ATPases—ATP2C2—chronic obstructive pulmonary disease	0.0162	0.157	CbGpPWpGaD
Esomeprazole—ATP4B—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00627	0.061	CbGpPWpGaD
Esomeprazole—ATP4B—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00559	0.0543	CbGpPWpGaD
Esomeprazole—ATP4A—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00559	0.0543	CbGpPWpGaD
Esomeprazole—ATP4A—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00498	0.0484	CbGpPWpGaD
Esomeprazole—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00349	0.0339	CbGpPWpGaD
Esomeprazole—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00308	0.03	CbGpPWpGaD
Esomeprazole—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00252	0.0245	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00218	0.0212	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00195	0.0189	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00195	0.0189	CbGpPWpGaD
Esomeprazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00191	0.0186	CbGpPWpGaD
Esomeprazole—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00174	0.0169	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00173	0.0169	CbGpPWpGaD
Esomeprazole—Rabeprazole—CYP1A1—chronic obstructive pulmonary disease	0.00151	0.167	CrCbGaD
Esomeprazole—Pantoprazole—CYP1A2—chronic obstructive pulmonary disease	0.00146	0.161	CrCbGaD
Esomeprazole—Rabeprazole—CYP1A2—chronic obstructive pulmonary disease	0.00146	0.161	CrCbGaD
Esomeprazole—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00139	0.0135	CbGpPWpGaD
Esomeprazole—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00128	0.0124	CbGpPWpGaD
Esomeprazole—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00126	0.0123	CbGpPWpGaD
Esomeprazole—Omeprazole—CYP1A1—chronic obstructive pulmonary disease	0.00123	0.136	CrCbGaD
Esomeprazole—Omeprazole—CYP1A2—chronic obstructive pulmonary disease	0.00119	0.131	CrCbGaD
Esomeprazole—Lansoprazole—CYP1A1—chronic obstructive pulmonary disease	0.00113	0.124	CrCbGaD
Esomeprazole—Lansoprazole—CYP1A2—chronic obstructive pulmonary disease	0.00109	0.12	CrCbGaD
Esomeprazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000981	0.00953	CbGpPWpGaD
Esomeprazole—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000919	0.00893	CbGpPWpGaD
Esomeprazole—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000884	0.00859	CbGpPWpGaD
Esomeprazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00076	0.00739	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000683	0.00664	CbGpPWpGaD
Esomeprazole—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000668	0.00649	CbGpPWpGaD
Esomeprazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00066	0.00642	CbGpPWpGaD
Esomeprazole—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000642	0.00624	CbGpPWpGaD
Esomeprazole—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000601	0.00584	CbGpPWpGaD
Esomeprazole—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000576	0.0056	CbGpPWpGaD
Esomeprazole—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000553	0.00537	CbGpPWpGaD
Esomeprazole—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000531	0.00517	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000529	0.00514	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000496	0.00482	CbGpPWpGaD
Esomeprazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00048	0.00467	CbGpPWpGaD
Esomeprazole—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000461	0.00448	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000441	0.00429	CbGpPWpGaD
Esomeprazole—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000437	0.00425	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000428	0.00416	CbGpPWpGaD
Esomeprazole—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000401	0.0039	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00039	0.00379	CbGpPWpGaD
Esomeprazole—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000386	0.00375	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000382	0.00371	CbGpPWpGaD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000382	0.00371	CbGpPWpGaD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000377	0.00366	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000361	0.00351	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000321	0.00312	CbGpPWpGaD
Esomeprazole—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00031	0.000961	CcSEcCtD
Esomeprazole—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.000961	CcSEcCtD
Esomeprazole—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000959	CcSEcCtD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000309	0.00301	CbGpPWpGaD
Esomeprazole—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.000952	CcSEcCtD
Esomeprazole—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000307	0.000952	CcSEcCtD
Esomeprazole—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00095	CcSEcCtD
Esomeprazole—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.000945	CcSEcCtD
Esomeprazole—Infection—Formoterol—chronic obstructive pulmonary disease	0.000305	0.000945	CcSEcCtD
Esomeprazole—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000937	CcSEcCtD
Esomeprazole—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000937	CcSEcCtD
Esomeprazole—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000937	CcSEcCtD
Esomeprazole—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000302	0.000937	CcSEcCtD
Esomeprazole—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.000934	CcSEcCtD
Esomeprazole—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000301	0.000933	CcSEcCtD
Esomeprazole—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000301	0.000933	CcSEcCtD
Esomeprazole—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000301	0.000932	CcSEcCtD
Esomeprazole—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000301	0.000932	CcSEcCtD
Esomeprazole—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0003	0.000929	CcSEcCtD
Esomeprazole—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0003	0.000929	CcSEcCtD
Esomeprazole—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000299	0.000926	CcSEcCtD
Esomeprazole—Infection—Montelukast—chronic obstructive pulmonary disease	0.000299	0.000926	CcSEcCtD
Esomeprazole—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.000925	CcSEcCtD
Esomeprazole—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.000924	CcSEcCtD
Esomeprazole—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000298	0.000924	CcSEcCtD
Esomeprazole—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000297	0.000921	CcSEcCtD
Esomeprazole—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.000917	CcSEcCtD
Esomeprazole—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000295	0.000914	CcSEcCtD
Esomeprazole—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000295	0.000913	CcSEcCtD
Esomeprazole—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000295	0.000912	CcSEcCtD
Esomeprazole—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000292	0.000905	CcSEcCtD
Esomeprazole—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.000898	CcSEcCtD
Esomeprazole—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.000893	CcSEcCtD
Esomeprazole—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.000888	CcSEcCtD
Esomeprazole—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000286	0.000885	CcSEcCtD
Esomeprazole—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.000884	CcSEcCtD
Esomeprazole—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000285	0.000883	CcSEcCtD
Esomeprazole—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.000881	CcSEcCtD
Esomeprazole—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000284	0.00276	CbGpPWpGaD
Esomeprazole—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.000877	CcSEcCtD
Esomeprazole—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.000873	CcSEcCtD
Esomeprazole—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.000869	CcSEcCtD
Esomeprazole—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.000869	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00028	0.000867	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.000867	CcSEcCtD
Esomeprazole—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.000861	CcSEcCtD
Esomeprazole—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000278	0.000861	CcSEcCtD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.00269	CbGpPWpGaD
Esomeprazole—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.000856	CcSEcCtD
Esomeprazole—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.000855	CcSEcCtD
Esomeprazole—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000852	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000274	0.000849	CcSEcCtD
Esomeprazole—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.000848	CcSEcCtD
Esomeprazole—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000274	0.000848	CcSEcCtD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000274	0.00266	CbGpPWpGaD
Esomeprazole—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000273	0.000846	CcSEcCtD
Esomeprazole—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000273	0.000846	CcSEcCtD
Esomeprazole—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000272	0.000843	CcSEcCtD
Esomeprazole—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.000838	CcSEcCtD
Esomeprazole—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00027	0.000838	CcSEcCtD
Esomeprazole—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00027	0.000837	CcSEcCtD
Esomeprazole—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.000834	CcSEcCtD
Esomeprazole—Injury—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000829	CcSEcCtD
Esomeprazole—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000268	0.000829	CcSEcCtD
Esomeprazole—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000267	0.000827	CcSEcCtD
Esomeprazole—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.000825	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000265	0.000821	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.000821	CcSEcCtD
Esomeprazole—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000265	0.00082	CcSEcCtD
Esomeprazole—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00082	CcSEcCtD
Esomeprazole—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00082	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.000819	CcSEcCtD
Esomeprazole—Pain—Formoterol—chronic obstructive pulmonary disease	0.000263	0.000814	CcSEcCtD
Esomeprazole—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000263	0.000814	CcSEcCtD
Esomeprazole—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.000814	CcSEcCtD
Esomeprazole—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.000814	CcSEcCtD
Esomeprazole—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000262	0.000813	CcSEcCtD
Esomeprazole—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000262	0.000811	CcSEcCtD
Esomeprazole—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.000807	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00026	0.000805	CcSEcCtD
Esomeprazole—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000259	0.000804	CcSEcCtD
Esomeprazole—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.000801	CcSEcCtD
Esomeprazole—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000799	CcSEcCtD
Esomeprazole—Pain—Montelukast—chronic obstructive pulmonary disease	0.000257	0.000797	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000257	0.0025	CbGpPWpGaD
Esomeprazole—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000257	0.000795	CcSEcCtD
Esomeprazole—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.000791	CcSEcCtD
Esomeprazole—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000255	0.00079	CcSEcCtD
Esomeprazole—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000255	0.000788	CcSEcCtD
Esomeprazole—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.000788	CcSEcCtD
Esomeprazole—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.000785	CcSEcCtD
Esomeprazole—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.000784	CcSEcCtD
Esomeprazole—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000253	0.000784	CcSEcCtD
Esomeprazole—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000253	0.000783	CcSEcCtD
Esomeprazole—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.000781	CcSEcCtD
Esomeprazole—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000252	0.00078	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.000778	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000251	0.000778	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.000776	CcSEcCtD
Esomeprazole—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.000775	CcSEcCtD
Esomeprazole—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.000768	CcSEcCtD
Esomeprazole—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.000768	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000246	0.000762	CcSEcCtD
Esomeprazole—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000762	CcSEcCtD
Esomeprazole—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000762	CcSEcCtD
Esomeprazole—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.000756	CcSEcCtD
Esomeprazole—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000244	0.000756	CcSEcCtD
Esomeprazole—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000243	0.000752	CcSEcCtD
Esomeprazole—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.000752	CcSEcCtD
Esomeprazole—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.000752	CcSEcCtD
Esomeprazole—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000243	0.000752	CcSEcCtD
Esomeprazole—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000242	0.00075	CcSEcCtD
Esomeprazole—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.000743	CcSEcCtD
Esomeprazole—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00024	0.000743	CcSEcCtD
Esomeprazole—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00024	0.000743	CcSEcCtD
Esomeprazole—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00074	CcSEcCtD
Esomeprazole—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00074	CcSEcCtD
Esomeprazole—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000239	0.000739	CcSEcCtD
Esomeprazole—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.000738	CcSEcCtD
Esomeprazole—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000238	0.000737	CcSEcCtD
Esomeprazole—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000238	0.000737	CcSEcCtD
Esomeprazole—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000736	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.000735	CcSEcCtD
Esomeprazole—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000727	CcSEcCtD
Esomeprazole—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000235	0.00228	CbGpPWpGaD
Esomeprazole—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.000714	CcSEcCtD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000229	0.00223	CbGpPWpGaD
Esomeprazole—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00071	CcSEcCtD
Esomeprazole—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00071	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000229	0.00223	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000226	0.0022	CbGpPWpGaD
Esomeprazole—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.000701	CcSEcCtD
Esomeprazole—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000226	0.000701	CcSEcCtD
Esomeprazole—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.0007	CcSEcCtD
Esomeprazole—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000226	0.000699	CcSEcCtD
Esomeprazole—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000698	CcSEcCtD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000225	0.00218	CbGpPWpGaD
Esomeprazole—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000693	CcSEcCtD
Esomeprazole—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000222	0.000687	CcSEcCtD
Esomeprazole—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.000683	CcSEcCtD
Esomeprazole—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00022	0.000683	CcSEcCtD
Esomeprazole—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000673	CcSEcCtD
Esomeprazole—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000673	CcSEcCtD
Esomeprazole—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000672	CcSEcCtD
Esomeprazole—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000672	CcSEcCtD
Esomeprazole—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000216	0.000669	CcSEcCtD
Esomeprazole—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000214	0.000663	CcSEcCtD
Esomeprazole—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000662	CcSEcCtD
Esomeprazole—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000659	CcSEcCtD
Esomeprazole—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00021	0.000651	CcSEcCtD
Esomeprazole—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.000651	CcSEcCtD
Esomeprazole—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000646	CcSEcCtD
Esomeprazole—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.000645	CcSEcCtD
Esomeprazole—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000207	0.000641	CcSEcCtD
Esomeprazole—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.002	CbGpPWpGaD
Esomeprazole—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000206	0.000638	CcSEcCtD
Esomeprazole—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000636	CcSEcCtD
Esomeprazole—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.000629	CcSEcCtD
Esomeprazole—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000203	0.000629	CcSEcCtD
Esomeprazole—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000199	0.000616	CcSEcCtD
Esomeprazole—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000616	CcSEcCtD
Esomeprazole—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.000615	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000198	0.00192	CbGpPWpGaD
Esomeprazole—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000606	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000195	0.0019	CbGpPWpGaD
Esomeprazole—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000195	0.000605	CcSEcCtD
Esomeprazole—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.000605	CcSEcCtD
Esomeprazole—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.0006	CcSEcCtD
Esomeprazole—Rash—Formoterol—chronic obstructive pulmonary disease	0.000194	0.0006	CcSEcCtD
Esomeprazole—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.000599	CcSEcCtD
Esomeprazole—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000194	0.000599	CcSEcCtD
Esomeprazole—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000599	CcSEcCtD
Esomeprazole—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.000596	CcSEcCtD
Esomeprazole—Headache—Formoterol—chronic obstructive pulmonary disease	0.000192	0.000596	CcSEcCtD
Esomeprazole—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000596	CcSEcCtD
Esomeprazole—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000595	CcSEcCtD
Esomeprazole—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.000594	CcSEcCtD
Esomeprazole—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000191	0.000593	CcSEcCtD
Esomeprazole—Rash—Montelukast—chronic obstructive pulmonary disease	0.00019	0.000588	CcSEcCtD
Esomeprazole—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00019	0.000587	CcSEcCtD
Esomeprazole—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000586	CcSEcCtD
Esomeprazole—Depression—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000585	CcSEcCtD
Esomeprazole—Headache—Montelukast—chronic obstructive pulmonary disease	0.000189	0.000584	CcSEcCtD
Esomeprazole—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000577	CcSEcCtD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.00181	CbGpPWpGaD
Esomeprazole—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.000571	CcSEcCtD
Esomeprazole—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000569	CcSEcCtD
Esomeprazole—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.000567	CcSEcCtD
Esomeprazole—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000566	CcSEcCtD
Esomeprazole—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000566	CcSEcCtD
Esomeprazole—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.000565	CcSEcCtD
Esomeprazole—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000183	0.000565	CcSEcCtD
Esomeprazole—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.000563	CcSEcCtD
Esomeprazole—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000179	0.000554	CcSEcCtD
Esomeprazole—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000545	CcSEcCtD
Esomeprazole—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000537	CcSEcCtD
Esomeprazole—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000534	CcSEcCtD
Esomeprazole—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.000531	CcSEcCtD
Esomeprazole—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000524	CcSEcCtD
Esomeprazole—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000518	CcSEcCtD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00162	CbGpPWpGaD
Esomeprazole—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000515	CcSEcCtD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.0016	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.0016	CbGpPWpGaD
Esomeprazole—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.000507	CcSEcCtD
Esomeprazole—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000503	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000162	0.00158	CbGpPWpGaD
Esomeprazole—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000498	CcSEcCtD
Esomeprazole—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000493	CcSEcCtD
Esomeprazole—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000489	CcSEcCtD
Esomeprazole—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000476	CcSEcCtD
Esomeprazole—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000466	CcSEcCtD
Esomeprazole—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000466	CcSEcCtD
Esomeprazole—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000463	CcSEcCtD
Esomeprazole—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000462	CcSEcCtD
Esomeprazole—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000459	CcSEcCtD
Esomeprazole—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.000441	CcSEcCtD
Esomeprazole—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000432	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000139	0.00135	CbGpPWpGaD
Esomeprazole—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000426	CcSEcCtD
Esomeprazole—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000425	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000137	0.00133	CbGpPWpGaD
Esomeprazole—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000424	CcSEcCtD
Esomeprazole—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000422	CcSEcCtD
Esomeprazole—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000419	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000135	0.00131	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.00131	CbGpPWpGaD
Esomeprazole—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000414	CcSEcCtD
Esomeprazole—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000412	CcSEcCtD
Esomeprazole—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000409	CcSEcCtD
Esomeprazole—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000396	CcSEcCtD
Esomeprazole—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000391	CcSEcCtD
Esomeprazole—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000391	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000126	0.00122	CbGpPWpGaD
Esomeprazole—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000389	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000388	CcSEcCtD
Esomeprazole—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000386	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000124	0.00121	CbGpPWpGaD
Esomeprazole—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00038	CcSEcCtD
Esomeprazole—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000374	CcSEcCtD
Esomeprazole—Infection—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000372	CcSEcCtD
Esomeprazole—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00116	CbGpPWpGaD
Esomeprazole—Shock—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000368	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000119	0.00116	CbGpPWpGaD
Esomeprazole—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000367	CcSEcCtD
Esomeprazole—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000365	CcSEcCtD
Esomeprazole—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00114	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000118	0.00114	CbGpPWpGaD
Esomeprazole—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000364	CcSEcCtD
Esomeprazole—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000362	CcSEcCtD
Esomeprazole—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000357	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000341	CcSEcCtD
Esomeprazole—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000341	CcSEcCtD
Esomeprazole—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000339	CcSEcCtD
Esomeprazole—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000336	CcSEcCtD
Esomeprazole—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00033	CcSEcCtD
Esomeprazole—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000326	CcSEcCtD
Esomeprazole—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000325	CcSEcCtD
Esomeprazole—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000325	CcSEcCtD
Esomeprazole—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000323	CcSEcCtD
Esomeprazole—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000323	CcSEcCtD
Esomeprazole—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00032	CcSEcCtD
Esomeprazole—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	9.96e-05	0.000309	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000306	CcSEcCtD
Esomeprazole—Nausea—Prednisolone—chronic obstructive pulmonary disease	9.88e-05	0.000306	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.88e-05	0.00096	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.74e-05	0.000947	CbGpPWpGaD
Esomeprazole—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.61e-05	0.000297	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	9.6e-05	0.000934	CbGpPWpGaD
Esomeprazole—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.000296	CcSEcCtD
Esomeprazole—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	9.56e-05	0.000296	CcSEcCtD
Esomeprazole—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	8.91e-05	0.000276	CcSEcCtD
Esomeprazole—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.68e-05	0.000269	CcSEcCtD
Esomeprazole—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000265	CcSEcCtD
Esomeprazole—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.000256	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.24e-05	0.000801	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.13e-05	0.00079	CbGpPWpGaD
Esomeprazole—Dizziness—Prednisone—chronic obstructive pulmonary disease	8e-05	0.000248	CcSEcCtD
Esomeprazole—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.69e-05	0.000238	CcSEcCtD
Esomeprazole—Rash—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000236	CcSEcCtD
Esomeprazole—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000236	CcSEcCtD
Esomeprazole—Headache—Prednisone—chronic obstructive pulmonary disease	7.58e-05	0.000235	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.57e-05	0.000736	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.47e-05	0.000726	CbGpPWpGaD
Esomeprazole—Nausea—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000222	CcSEcCtD
Esomeprazole—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.18e-05	0.000698	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.08e-05	0.000688	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.85e-05	0.000666	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.36e-05	0.000618	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.31e-05	0.000613	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	6.19e-05	0.000602	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.78e-05	0.000561	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.75e-05	0.000559	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.58e-05	0.000446	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.83e-05	0.000372	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.72e-05	0.000362	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.46e-05	0.000336	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.38e-05	0.000329	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	3.34e-05	0.000325	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.12e-05	0.000303	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	3.05e-05	0.000296	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.81e-05	0.000273	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.34e-05	0.000228	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.31e-05	0.000225	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.15e-05	0.000209	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.04e-05	0.000198	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.03e-05	0.000198	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.01e-05	0.000195	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.83e-05	0.000178	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000164	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.41e-05	0.000137	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.39e-05	0.000135	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.39e-05	0.000135	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.33e-05	0.000129	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000126	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.000119	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.34e-06	8.11e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.98e-06	7.76e-05	CbGpPWpGaD
